We are lowering our target price of Bristol Myers despite a profit rate
Bristol Myers Squibb and Rosy Outlook's profits on Thursday did not solve persistent problems for actions. But it was enough,…
johnson and johnson
Medical products manufacturers are divided over Trump's rates
President Donald Trump's tariffs are creating a division in the medical community. The medical devices and the protection team carried…
Drug manufacturers comments on Trump's pharmaceutical rates
A worker is working on a drug production line in the production workshop of a pharmaceutical company in Meishan, China,…
Trump says that pharmaceutical rates are arriving, the actions fall
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters The actions of drug…
Trump tariffs will challenge the big pharmaceuticals. Here are well positioned actions
Long Data Commercial Agreements have greatly protected the pharmaceutical industry of tariffs, but the objective of President Donald Trump to…
Medicare publishes prices for the first 10 drugs subject to negotiations
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
Pharmaceutical companies negotiate new prices with Medicare
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris…
These are the top pharmaceutical stocks selected by JPMorgan for its results
JPMorgan is eyeing some drugmakers ahead of their earnings reports as investors continue to sell shares of major technology companies.…
First round of Medicare drug price negotiations nearing end
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
Cramer says it's better to come to Oracle, also look at BIRK, JNJ, PARA, CASY
Jim Cramer's daily rapid-fire breaks down stocks in the news outside of the CNBC Investing Club portfolio. Oracle: The tech…